About Lisbon Addictions 2017

Practical information including directions to the venue (PDF)

Lisbon Addictions 2017, the second European Conference on Addictive Behaviours and Dependencies, is a multidisciplinary conference that provides a forum for networking across the addictions.

Over 600 participants from 58 countries attended Lisbon Addictions 2015. The conference sold out several months before the event. See presentations and posters

Once again, the conference will be jointly organised by the Portuguese General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD), the journal Addiction, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the International Society of Addiction Journal Editors (ISAJE).

Press release

(19 July 2017) Lisbon hosts Second European conference on addictive behaviours and dependencies (PDF) — English, Portuguese

Subscribe to our newsletter


Download programme (PDF) – Last update 18.10.17

Guidelines for presenters and chairs (PDF)

The programme is organised/developed around plenary sessions, oral presentations in open sessions, structured sessions (symposia/panel discussions/workshops) and poster presentations. Sessions are scheduled in different time slots commencing Tuesday 24 October and closing on Thursday 26 October. All participants should ensure their availability for all time slots.

Keynote speakers and chairs

Joël Billieux

Associate Professor of Clinical Psychology, Head of Addictive and Compulsive Behaviour Lab, Institute for Health and Behaviour, University of Luxembourg, Luxembourg

Henrietta Bowden-Jones

Consultant Psychiatrist, Director and Lead Clinician, National Problem Gambling Clinic. Honorary Clinical Senior Lecturer, Faculty of Medicine, Imperial College London, UK

Torbjørn K. Brekke

Senior Drug Policy Advisor, Ministry of Health and Care Services, Department of Public Health, Oslo, Norway

Chloé Carpentier

Chief, Drug Research Section, United Nations Office on Drugs and Crime, Austria

Catherine Comiskey

Professor in Healthcare Modelling, School of Nursing & Midwifery, University of Dublin, Trinity College, Ireland

Louisa Degenhardt

NHMRC Principal Research Fellow, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia

Alexis Goosdeel

Director, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal

João Goulão

Director, Serviço de Intervenção nos Comportamentos Aditivos e nas Dependências (SICAD), Lisbon, Portugal

Christopher Jones

Acting Associate Deputy Assistant Secretary, Science and Data Policy, Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services, USA

Sabrina Molinaro

ESPAD Coordinator, Head of Epidemiology and Health Research Lab, Institute for Clinical Physiology, National Research Council, Italy

Ann McNeill

Professor of Tobacco Addiction, National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK

Rosalie Liccardo Pacula

Professor, Pardee RAND Graduate School, RAND Corporation, USA

Letizia Paoli

Full Professor of Criminology, Faculty of Law, University of Leuven, Belgium

Vladimir Poznyak

Coordinator, Management of Substance Abuse, Department of Mental Health and Substance Abuse, World Health Organization

Alexandre Quintanilha

President of the Ethics Committee for Clinical Research. President of the Parliamentary Commission on Education and Science, Portugal

Jürgen Rehm

Senior Director, Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada

Alison Ritter

Professor and Director, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Australia

Werner Sipp

Consultant, former President of the International Narcotics Control Board of the United Nations, Germany

Rainer Spanagel

Professor of Pharmacology & Toxicology, Scientific Director, Institute of Psychopharmacology, Central Institute of Mental Health, Heidelberg University, Germany

Kerstin Stenius

Research Manager, National Institute for Health and Welfare, Helsinki. Docent, Helsinki University, Finland.Researcher, Centre for Social Research on Alcohol and Drugs, Stockholm University, Sweden.

Ute Stiegel

Deputy Head of Unit, Organised crime and drugs policy, European Commission - DG HOME

Jallal Toufiq

The Moroccan Observatory on Drugs and Addictions, Morocco

Speaker 6

Marie Claire Van Hout

Professor of Public Health Policy and Practice, Public Health Institute, Liverpool John Moore's University, UK

Side events and networking

LxAddictions17 will again provide a unique networking opportunity for researchers, practitioners and policy experts across countries and disciplines, addressing new challenges and covering developing fields. In the margins of the conference various major events will take place. Already confirmed are the following:

  • 24-25 October 2017
    • TWIST — Training With Stakeholders – applying EU drug research: The EC-funded TWIST project will provide a two-day training programme, aimed at early-stage addiction professionals, embedded within the scope and programme of LxAddictions17.

Please note that participants need to register separately for side‑events.

To promote networking, conference rooms will be available for side events. If interested please contact us at: lisbonaddictions2017@abreu.pt

Registration – Now closed

Please note that Lisbon has become a popular location for many congresses and other major events. We strongly advise you to book your hotel well in advance by contacting the Local Management Company.

Looking for tips on exploring Lisbon and nearby destinations? Our local partners have arranged for a tour organising company to be on site at LxAddictions17, but you may already select and book your tours and visits at Cityrama.

Registration (for accredited media only)


Place of exhibition

Praça das Indústrias
1300-307 Lisbon

Tel: (+351) 21 360 1400

Fax: (+351) 21 360 1499



Avenida 25 de Abril, 2
2799-556 Linda-a-Velha

Tel: (+351) 21 415 6120

Fax: (+351) 21 415 6383

E-mail: helder.carvalho@abreu.pt


Please contact the local exhibition management company to receive further information about the exhibition (set-up, dismantling, stands, furniture, terms & conditions, order forms, etc.)

Organisers and partners


International organisations

Collaborative partners

Supporting organisations

  • Judith Aldridge (Senior Lecturer, School of Law, University of Manchester, UK)
  • Hannu Alho (ISAM  President, Professor of Addiction Medicine, Finland)
  • Alexander Baldacchino (Professor of Medicine, Psychiatry and Addictions, University of St Andrews, UK)
  • Henri Bergeron (Chair in Health Studies, Sciences Po Paris, France)
  • Virginia Berridge (Professor of History and Director, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, UK)
  • Kim Bloomfield (Professor, Center for Alcohol and Drug Research, Aarhus University, Denmark)
  • Henrietta Bowden-Jones (Consultant Psychiatrist. Founder and Director, National Problem Gambling Clinic, UK)
  • Jørgen G. Bramness (Senior researcher, Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Norwegian Centre of Dual Diagnosis)
  • Anne Line Bretteville-Jensen (Research Director, Norwegian Institute for Alcohol and Drug Research (SIRUS), Norway)
  • Angelina Brotherhood (Public Health Researcher, Liverpool John Moores University, UK)
  • Gerhard Bühringer (Chair of Addiction Research, Institute for Clinical Psychology and Psychotherapy, Technische Universität Dresden, Germany)
  • Catherine Comiskey (Head of School of Nursing and Midwifery, Trinity College, Ireland)
  • Ornella Corazza (Reader in Substance Addictions and Behaviours, University of Hertfordshire, Hatfield, UK)
  • Paul Dargan (Consultant Physician and Clinical Toxicologist, Guy's and St Thomas' NHS Foundation Trust, and Reader in Toxicology, King’s College London, UK)
  • Marina Davoli (Head, Department of Epidemiology, National Agency for Health Services, Italy)
  • Louisa Degenhardt (Professor, National Drug and Alcohol Research Centre (NDARC), Australia)
  • Fernando Rodríguez de Fonseca (Fundación IMABIS, Hosp. Univ. Carlos Haya de Málaga, Spain)
  • Brice de Ruyver (Full Professor criminal law and criminology, Director Institute for International Research on Criminal Policy, Ghent University, Belgium)
  • Fabrizio Faggiano (Professor of Public Health at the Department of Translational Medicine of the University of the Piemonte Orientale, Italy)
  • Michael Farrell (Director, National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Australia)
  • Gabriele Fischer (Medical Director of the Addiction Clinic at the Medical University Vienna, Austria)
  • Henk Garretsen (Professor, Director Tranzo, Scientific Centre for Care and Welfare, Tilburg University, The Netherlands)
  • Eilish Gilvarry (President of the Society for the Study of Addiction, Honorary Professor of Addiction Psychiatry, Newcastle University, UK)
  • Manuela Grazina (Professor, Faculty of Medicine; Researcher and Head of Laboratory of Biochemical Genetics, Center for Neuroscience and Cell Biology; University of Coimbra, Portugal)
  • Antoni Gual (Director of the Addictions Unit, Hospital Clínic Barcelona, Spain)
  • Wayne Hall (Professor, Director and Inaugural Chair, Centre for Youth Substance Abuse Research, The University of Queensland, Australia)
  • Matthew Hickman (School of Social and Community Medicine, University of Bristol, UK)
  • Susana Jiménez-Murcia (Head of Pathological Gambling Unit, Department of Psychiatry, University Hospital of Bellvitge, Barcelona, Spain)
  • Beau Kilmer (Co-director and senior policy researcher, RAND Drug Policy Research Center; Professor, Pardee RAND Graduate School, USA)
  • Dirk Korf (Professor, Bonger Institute of Criminology, University of Amsterdam, The Netherlands)
  • Krzysztof Krajewski (Chair of Criminology, Jagiellonian University, Poland)
  • Ludwig Kraus (Director, IFT Institut für Therapieforschung, Munich, Germany)
  • Håkan Leifman (Director, Swedish Council for Information on Alcohol and Other Drugs (CAN), Sweden)
  • Henrique Lopes (President of the Ibero-latin-american Scientific Society for Gambling Research, Chair of CEIA research center, researcher at Public Healthcare Unit of Catholic University - ICS)
  • Pia Mäkelä (Head of Alcohol and Drugs Unit, National Institute for Health and Welfare, Finland)
  • Meni Malliori (Associate Professor of Psychiatry, Medical School, National & Kapodistrian University of Athens, Greece)
  • Rebecca McKetin (Associate Professor, ANU College of Medicine, Biology and Environment, Australia)
  • Angela Me (Chief of the Research and and Trend Analysis Branch, United Nations Office on Drugs and Crime)
  • Lars Møller (Programme Manager Alcohol & Illicit Drugs and Prison Health, World Health Organization Regional Office for Europe)
  • Catherine Moury (Assistant Professor of political Science, FCSH, Universidade Nova de Lisboa, Portugal)
  • Emília Nunes (Professor, Director of the National Programme for Prevention of Smoking and Tobacco Control, General-Directorate of Health, Portugal)
  • Letizia Paoli (Professor, Leuven Institute of Criminology, University of Leuven, Faculty of Law, Belgium)
  • Amy Porath-Waller (Director, Research and Policy, Canadian Centre on Substance Abuse, Canada)
  • Jürgen Rehm (Director, Social and Epidemiological Research (SER) Department, Centre for Addiction and Mental Health, Toronto, Canada)
  • Xavier Majó i Roca (Office of Drug Addiction, Public Health Agency of Catalonia, Spain)
  • Zila M. Sanchez (Professor of Epidemiology, Preventive Medicine Department, Universidade Federal de São Paulo, Brazil)
  • Emanuele Scafato (Director of Population’s Health and Health Determinants Unit in the National Centre for Epidemiology, Surveillance and Health Promotion-CNESPS at the Istituto Superiore di Sanità, Italy)
  • Janusz Sieroslawski (Institute of Psychiatry and Neurology, Poland)
  • Jussi Simpura (Chair, Finnish Foundation for Alcohol Studies)
  • Zili Sloboda (President, Applied Prevention Science, Inc., USA)
  • Rainer Spanagel (Professor of Pharmacology & Toxicology, Head of the Institute of Psychopharmacology, University of Heidelberg, Germany)
  • Kerstin Stenius (Ass. Prof., Centre for Social Research on Alcohol and Drugs, Stockholm University, Sweden; Alcohol and Drugs unit, National Institute for Health and Welfare, Finland; and Nordic Centre for Welfare and Social Issues, Finland)
  • John Strang (Professor, Head of the Addictions Department, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London, UK)
  • Harry Sumnall (Professor, Centre for Public Health, Liverpool John Moores University, UK)
  • Margriet Van Laar (Head of the Department Drug Monitoring, Trimbos Institute, The Netherlands)
  • Julian Vicente (Head of the prevalence, consequences and data management unit, EMCDDA)
  • Graça Vilar (Director of the Planning and Intervention Department of SICAD, Master in forensic medicine and forensic sciences, Graduate Assistant of Psychiatry Hospital, Portugal)
  • Chris Wilkins (Senior Researcher, Drugs Team Leader, SHORE & Whariki Research Centre, College of Health, Massey University, Auckland, New Zealand)

Co-chairs: Manuel Cardoso (SICAD), Paul Griffiths (EMCDDA)

  • Robert West (Addiction/Society for the Study of Addiction)
  • Ann McNeill (Addiction/Society for the Study of Addiction)
  • Richard Pates (ISAJE)
  • Michal Miovsky (ISAJE)
  • Ana Sofia Santos (SICAD)
  • Ana Rodrigues (SICAD)
  • Maria Moreira (EMCDDA)
  • Liesbeth Vandam (EMCDDA)
  • Manuel Cardoso (SICAD)
  • Ana Sofia Santos (SICAD)
  • Ana Rodrigues (SICAD)
  • Filipa Cunha (SICAD)
  • Sónia Ferreira (SICAD)
  • Alexandra Pinto (SICAD)
  • Paul Griffiths (EMCDDA)
  • Maria Moreira (EMCDDA)
  • Liesbeth Vandam (EMCDDA)
  • Marie-Christine Ashby (EMCDDA)
  • Silke Vitt (EMCDDA)
  • Renate Hochwieser (EMCDDA)
  • Prem Borle (EMCDDA)
  • Alberto Oteo